Background The emergence of multiple-drug-resistant
T yphoid fever is a systemic infection caused by the bacterium Salmonella typhi typhoid fever is still an endemic disease with high incidence. The emergence of multiple-drugSalmonella typhi strains resistant to chloramphenicol, ampicillin and trimethoprimnew agents for the treatment of typhoid fever. Relapse and chronic carriage was found after chloramphenicol therapy. Side effects of chloramphenicol such as bone marrow depression and aplastic anemia have also forced physicians to seek alternatives to therapy with chloramphenicol.
Azithromycin is a derivative of the basic macrolide with better activity than erythromycin against Gram enteric pathogens, including Salmonella spp. However, there is not enough evidence to compare azithromycin with the first-line antibiotics currently used. The objective of this study was to analyze the efficacy of azithromycin, a new macrolide, compared to that of chloramphenicol, as a first-line drug for therapy of uncomplicated typhoid fever in children.
Methods
We conducted a randomized open trial from Kandou Hospital, Manado. The study was approved by the Ethics Committee of Sam Ratulangi University uncomplicated typhoid fever. Uncomplicated typhoid fever was defined as a history of documented fever clinical features suggestive of typhoid fever (abdominal pain and tenderness, diarrhea or constipation, nausea consent was provided by all subjects' parents prior malnutrition, history of hypersensitivity reactions to azithromycin or chloramphenicol, history of S. enteritidis infection, other diseases such as dengue fever, malaria, pneumonia, tuberculosis or urinary tract infection, as well as those who had received who had taken other antibiotics.
Subjects were randomly assigned based on a random list generated by computer to receive either tests and urinalyses were performed before therapy. Additional urine cultures were performed in patients with white blood cell counts greater than 5 cells per high power field in their urinalyses, to rule out urinary tract infection. discharge, with particular reference to clinical symptoms, fever clearance time, any side effects of the drugs, and any complications of the disease. The response to treatment was assessed by clinical fever clearance time (time in hours from the start of antibiotic administation until body temperature fell considered cured if their fever disappeared, all signs and symptoms of typhoid fever resolved, and there was no complication or severe side effect up to the last day of the treatment. A clinical treatment failure was defined as the persistence of fever and symptoms after completing the treatment or the development of severe complications (severe gastrointestinal bleeding, cure proportions were compared with the Chi-square test. The fever clearance times were compared using significant difference between the two groups.
Results
were recruited into our study. Three children from the azithromycin group and two children from the chloramphenicol group were subsequently dropped Table 1 shows the epidemiological, clinical, and laboratory features between study groups. There were most common presenting feature after fever, followed by nausea and vomiting. Complete blood count laboratory values on admission were within normal limits for both study groups. Table 2 shows the treatment outcome for both groups. Fever clearance time was shorter in the All patients treated with azithromycin and all but two of the patients treated with chloramphenicol were cured. The two patients with clinical failures in the chloramphenicol group were considered to be not cured as a result of their slow fever resolution without other symptoms. These two subjects received Table 2 95% CI 95% CI of chloramphenicol. Both of them subsequently had complete cures without significant consequences. Adverse events occurred in two patients treated with azithromycin, with the development of abdominal discomfort and cough, but in none of the patients treated with chloramphenicol. The adverse events were not severe and did not result in medication changes.
Discussion
The results of this comparative, randomized trial of azithromycin and chloramphenicol for typhoid fever indicated that both treatments were similarly subjects who received azithromycin compared favorably with findings from past azithromycin trials for treatment of typhoid fever. 5 The mean fever treatment in the two treatment groups indicated that most patients responded promptly to therapy. These results compared favorably with other antimicrobial as well as Vietnam in which azithromycin was deemed effective against infections caused by S. typhi. clearance times were shorter than those of past trials.
Butler et al. 5 reported that in adult patients randomized to receive either azithromycin clearance times were shorter in the azithromycin not statistically significant. There was marked heterogeneity for fever clearance times in children and adults using azithromycin for typhoid in past studies et al. et al. et al. et al. et al. found that fever clearance time in children and adolescents with clinical typhoid fever who were treated with The discrepancy in fever clearance times between trials may be caused by various factors, including methodological differences, different geographical locations, age of the study group, the dose of drugs used, severity of disease or clinical condition of patients, previous antibiotic treatment and immune where MDR S. typhi have been reported, including
A prospective study performed in Delhi at intervals of three years
MDR S. typhi
Another past trial was conducted in Southern Vietnam, an area characterized by a very Unlike other regions of Southeast Asia where MDR was common, reported levels of antibiotic resistance in S. typhi -in some studies that, as compared with the children infected by sensitive S. typhi strains, children with MDR S. typhi -tion. clearance times in our study for both antibiotic groups.
prior to enrollment. This could also have influenced the fever clearance times, though the proportion of subjects' receiving previous antibiotics between the study groups was similar. The two drugs studied here were different in regard to their administration, pharmacokinetics, therapeutic principles and side effects. Azithromycin cells effectively, and this intracellular penetration predominantly intracellular pathogen S. typhi. On the other hand, serum concentrations of azithromycin
S. typhi.
treatment of typhoid fever. The ability of azithromycin to achieve intracellular concentrations in monocytes than the serum concentrations, as well as a long appears to be essential for azithromycin's therapeutic activity in typhoid fever.
Adverse events, including gastrointestinal symptoms and cough, were reported by two patients treated with azithromycin in our trial, but these events were not serious and did not require discontinuation of therapy. These events principally occurred within the or alteration of the treatment regimen. Although it cannot be proven, many of the gastrointestinal events were likely associated with the underlying disease and not with the treatment.
This study was not a blinded trial, which is one of its limitations. Another limitation was that we did not perform blood cultures as the gold standard to diagnose typhoid fever, nor did we perform antimicrobial sensitivity tests on the bacteria. similar to that of choramphenicol in the treatment of uncomplicated typhoid fever in children. Azithromycin shows shorter fever clearance time and higher cure rates compared to chloramphenicol, in the therapy of uncomplicated typhoid fever in children, although these results are not statistically significant. 
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